Medication info
Lisednil Plus Tablet

Lisednil Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets/PTP packaging
Approval status
Active

MFDS item code 201606083 · Approved 2016.10.14 · Insurance code 646004300

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Take 1 tablet orally once weekly Older adults: No dose adjustment is necessary in older adults (60 years of age or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min). Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this medicine. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides a week's supply of vitamin D at 800 IU daily when taken once weekly. If a patient forgets to take a dose on the scheduled day, take it on the day the patient remembers. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy of this medicine have not been established in children or growing adolescents.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis that may occur in postmenopausal women, and it is also effective in treating osteoporosis in men. It helps prevent bones from becoming weak or fracturing easily due to osteoporosis and improves bone health. It plays a significant role in increasing bone mineral density and reducing the risk of fractures. Therefore, this medication is used to manage osteoporosis and maintain strong bones.

How to take

Adult dose

Adults: Take 1 tablet orally once weekly Older adults: No dose adjustment is necessary in older adults (60 years of age or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min). Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this medicine. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides a week's supply of vitamin D at 800 IU daily when taken once weekly. If a patient forgets to take a dose on the scheduled day, take it on the day the patient remembers. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy of this medicine have not been established in children or growing adolescents.

Precautions

This medication can irritate the gastrointestinal mucosa, which may lead to esophageal problems such as esophagitis or esophageal ulcers. If symptoms such as difficulty swallowing, pain behind the sternum, or heartburn occur during use, discontinue use immediately and consult a physician. Take this medication with a sufficient amount of water (170-230 mL), and do not lie down for at least 30 minutes after taking it. Patients with esophageal motility disorders, hypocalcemia, or severe renal impairment should not take this medication. This product contains lactose and should not be used by patients with lactose intolerance. It is advisable not to take this medication with drugs or food containing divalent cations such as calcium or magnesium. This medication may require supplementation if calcium and vitamin D intake is insufficient, particularly in patients receiving long-term steroid therapy. Consult a specialist before dental treatment, as there is a risk of jaw osteonecrosis. Pregnant or nursing women should consult their physician before use, and it is recommended to discontinue use or breastfeeding during treatment. Safety and efficacy in children have not been established; hence, use should be cautious. Elderly patients can use it without special caution, but must be closely monitored for dosing and adverse reactions. In case of overdose, serum calcium and phosphorus levels may decrease; if hypocalcemia symptoms appear, immediate treatment is required.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • hypocalcemia
Show 113 more
  • hypophosphatemia
  • infection
  • lumbago
  • pain
  • abdominal pain
  • throat pain
  • weakness
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • distention
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • hypertonicity
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • pruritus
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • dry mouth
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • hypercholesterolemia
  • upper abdominal pain
  • gastrointestinal gas
  • abdominal bloating
  • hiatal hernia
  • dry mouth
  • influenza
  • nasopharyngitis
  • upper respiratory tract inflammation
  • lumbago
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • neck pain
  • weakness
  • fever
  • headache
  • dizziness
  • cough
  • edema
  • facial swelling
  • hair loss
  • abnormal olfaction
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • jawbone necrosis
  • liver function impairment
  • jaundice
  • external ear bone necrosis
  • decreased appetite
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is best to keep it at room temperature, between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/PTP packaging

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.